SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $100,130 | +428.6% | 3,331 | +527.3% | 0.01% | +600.0% |
| Q4 2022 | $18,941 | -66.8% | 531 | -68.6% | 0.00% | -75.0% |
| Q3 2022 | $57,000 | -65.2% | 1,689 | -72.7% | 0.00% | -66.7% |
| Q3 2021 | $164,000 | +264.4% | 6,183 | +257.2% | 0.01% | +200.0% |
| Q1 2021 | $45,000 | -76.8% | 1,731 | -68.9% | 0.00% | -77.8% |
| Q1 2019 | $194,000 | +2.6% | 5,562 | -2.4% | 0.02% | -5.3% |
| Q4 2018 | $189,000 | +67.3% | 5,700 | +153.1% | 0.02% | +137.5% |
| Q3 2018 | $113,000 | +11.9% | 2,252 | +1.8% | 0.01% | -11.1% |
| Q1 2018 | $101,000 | -65.6% | 2,212 | -70.1% | 0.01% | -66.7% |
| Q4 2017 | $294,000 | +18.5% | 7,393 | +19.1% | 0.03% | +12.5% |
| Q3 2017 | $248,000 | +1358.8% | 6,208 | +607.9% | 0.02% | +1100.0% |
| Q2 2016 | $17,000 | -90.8% | 877 | -91.9% | 0.00% | -93.9% |
| Q2 2015 | $184,000 | +2528.6% | 10,889 | +1714.8% | 0.03% | +1550.0% |
| Q1 2015 | $7,000 | -85.7% | 600 | -89.2% | 0.00% | -83.3% |
| Q1 2014 | $49,000 | – | 5,544 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |